[Pulmonary side effects of bleomycin therapy]

Bleomycin is now firmly established in the treatment of germinative scrotal tumors. Because of its low bone-marrow toxicity it is used for a number of malignant diseases in combination with other cytostatic drugs. However, the pulmonary toxicity of Bleomycin therapy was pointed out at an early stage: it can lead to a fatal lung fibrosis (Blum et al. 1973). This paper considers the pulmonary side-effects on the basis of a case observed by the author.